AI assistant
Sending…
Dare Bioscience, Inc. — Director's Dealing 2014
Oct 7, 2014
34825_dirs_2014-10-07_9834493f-adf0-449e-82d0-6e86b9604e7e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2014-10-03
Reporting Person: Kelley Susan L. (Director)
More from Dare Bioscience, Inc.
Proxy Solicitation & Information Statement
2026
Jun 1
Proxy Solicitation & Information Statement
2026
Jun 1
Capital/Financing Update
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Regulatory Filings
2026
Apr 22
Board/Management Information
2026
Apr 17
Capital/Financing Update
2026
Apr 13